Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HBM | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | HR | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | STARD9 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | ATP5F1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | PARK7 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | RPL7A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | WIPI1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
mRNA | HBA2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | CKS2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | ARCN1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |